Renlin Zheng

SKLB1002, a Novel Potent Inhibitor of VEGF Receptor 2 Signaling, Inhibits Angiogenesis and Tumor Growth <i>In Vivo</i>

Shuang Zhang, Zhixing Cao, Hongwei Tian et al. · Clinical Cancer Research · 2011 · 101 citations

Medicine, Oncology, Pharmacology +15

Novel binding regioselectivity in the interpenetration of a non-symmetric axle into a non-symmetric pillar[5]arene wheel

Xiaoyan Shu, Wei Chen, Dabin Hou et al. · Chemical Communications · 2014 · 82 citations

Natural Sciences, Chemistry, Medicinal Chemistry +11

Discovery of Novel Pim-1 Kinase Inhibitors by a Hierarchical Multistage Virtual Screening Approach Based on SVM Model, Pharmacophore, and Molecular Docking

Ji-Xia Ren, Linli Li, Renlin Zheng et al. · Journal of Chemical Information and Modeling · 2011 · 73 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Novel thienopyridine derivatives as specific anti-hepatocellular carcinoma (HCC) agents: Synthesis, preliminary structure–activity relationships, and in vitro biological evaluation

Xiu‐Xiu Zeng, Renlin Zheng, Hai‐Yun He et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 71 citations

Pharmacy, Medicinal Chemistry, Pharmacology +9

Structural Optimization and Structure–Activity Relationships of <i>N</i>²-(4-(4-Methylpiperazin-1-yl)phenyl)-<i>N</i>⁸-phenyl-9<i>H</i>-purine-2,8-diamine Derivatives, a New Class of Reversible Kinase Inhibitors Targeting both EGFR-Activating and Resistance Mutations

Jiao Yang, Lijiao Wang, Jingjing Liu et al. · Journal of Medicinal Chemistry · 2012 · 57 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15